"Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds"
- Sponsor
- Sinai University
- Study ID
- NCT07099482
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Chronic Wound Healing
- Diabetic Foot Ulcer t
- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Wound Management
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Sham ultrasound (placebo) — DEVICEParticipants will receive conventional wound care including debridement, cleaning, and dressing. A sham ultrasound device that emits no therapeutic waves will be applied to simulate the intervention procedure.
- Propolis gel (10%) — DRUGParticipants will receive topical application of 10% propolis gel on the diabetic foot ulcer followed by therapeutic ultrasound (phonophoresis) using 1 MHz frequency, 0.5-1.5 W/cm² intensity, pulsed mode (20%), for 5 minutes per session, 3 sessions/week for 4 weeks.
Study Details
This study aims to evaluate whether using ultrasound (phonophoresis) can help deliver propolis-a natural compound made by bees-more effectively into the skin to speed up wound healing in people with diabetic foot ulcers. Diabetic foot ulcers are a common and serious complication of diabetes and often take a long time to heal. Propolis has natural anti-inflammatory and antimicrobial properties that may promote healing, but it does not easily penetrate the skin. By using ultrasound to enhance absorption, this study tests whether combining propolis with phonophoresis is more effective than standard wound care alone. Participants will be randomly assigned to receive either the propolis ultrasound therapy or standard care. The study will measure wound size, healing time, pain, infection rates, and quality of life.
Key Dates
- First listed
- Aug 1, 2025
- Start date
- May 30, 2026
- Status verified
- May 2026
- Primary completion
- Aug 25, 2026
- Completion
- Sep 25, 2026
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Experimental: Propolis PhonophoresisParticipants will receive topical application of 10% propolis gel on the diabetic foot ulcer followed by therapeutic ultrasound (phonophoresis) using 1 MHz frequency, 0.5-1.5 W/cm² intensity, pulsed mode (20%), for 5 minutes per session, 3 sessions/week for 4 weeks .Interventions: * Drug: Propolis gel (10%) * Device: Therapeutic ultrasound (phonophoresis)
- Placebo Comparator: Standard Wound Care + Sham UltrasoundParticipants will receive conventional wound care including debridement, cleaning, and dressing. A sham ultrasound device that emits no therapeutic waves will be applied to simulate the intervention procedure. Interventions: * Other: Standard wound care procedures * Device: Sham ultrasound (placebo)
Primary Outcome Measure
Percentage Reduction in Wound Area [ Time Frame: Baseline to Week 4 ]
Find similar trials
Related Studies
- Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft LossRecruiting · Rodolfo Alejandro · Miami, Florida
- Long Term Follow up of Recipients of Functional Islet AllograftsRecruiting · Rodolfo Alejandro · Miami, Florida
- Long Term Surveillance of Islet Transplant Recipients Following Complete Graft LossRecruiting · Rodolfo Alejandro · Miami, Florida
- Type 1 Diabetes Extension StudyRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California